Highly translational assays

VitroScan offers predictive testing solutions to support the clinical stage development of innovative novel drugs. Providing accurate evaluation of patients’ sensitivity to drugs of all therapy classes. The platform combines advanced tumor testing in the native tumor microenvironment with AI algorithms to rank patient sensitivity to standard of care drugs multiple and benchmark the efficacy of novel therapies.

News & Events